Gill, D; Burgess, S
(2020)
Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes.
Circ Genom Precis Med, 13 (5).
pp. 551-553.
ISSN 2574-8300
https://doi.org/10.1161/CIRCGEN.120.003061
SGUL Authors: Gill, Dipender Preet Singh
Item Type: |
Article
|
Additional Information: |
© 2020 The Authors. Circulation: Genomic and Precision Medicine is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
Keywords: |
Mendelian randomization analysis, cardiovascular disease, coronary artery disease, serine protease |
SGUL Research Institute / Research Centre: |
Academic Structure > Infection and Immunity Research Institute (INII) |
Journal or Publication Title: |
Circ Genom Precis Med |
ISSN: |
2574-8300 |
Language: |
eng |
Dates: |
Date | Event |
---|
October 2020 | Published | 13 August 2020 | Published Online | 1 July 2020 | Accepted |
|
Publisher License: |
Creative Commons: Attribution 4.0 |
Projects: |
|
PubMed ID: |
33079601 |
![](http://static.pubmed.gov/portal/portal3rc.fcgi/2745237/img/27842) |
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/112761 |
Publisher's version: |
https://doi.org/10.1161/CIRCGEN.120.003061 |
Statistics
Item downloaded times since 08 Jan 2021.
Actions (login required)
![Edit Item](/style/images/action_view.png) |
Edit Item |